Cell-cycle progression panel identifies prostate cancer risk
(HealthDay)—The cell-cycle progression (CCP) gene panel is useful to improve the risk stratification for men with even low-risk, clinically localized prostate cancer, according to research published online March 4 in the ...
Mar 28, 2013
0
0